Health Law Webinar - What You Need to Know About EKRA

In October 2019, the President signed the SUPPORT for Patients and Communities Act, a portion of which is known as “Eliminating Kickbacks in Recovery Act of 2018,” or “EKRA.” EKRA, ostensibly aimed at the ongoing opioid crisis, is meant to prevent patient brokering, referrals and kickbacks related to drug recovery and substance abuse centers. EKRA’s language, however, is very broad, goes well beyond the opioid crisis, and carries significant penalties.

  • Please join us as we review this recent law. We will discuss:
  • Congress' intent in enacting EKRA;
  • How the language of EKRA goes beyond the opioid crisis and recovery centers, including laboratories;
  • The ambiguity of what might be considered a "referral" under EKRA;
  • Why you may need to evaluate compliance with both EKRA and the Anti-Kickback Statute; and
  • EKRA's penalty scheme

Agenda: THURSDAY, JUNE 27, 2019
12:00 - 1:00 PM MDT

Speaker: Eric Maxfield

Location: Webinar Only

Questions? Please contact Laura Squyres.

DISCLAIMER

Unless you are a current client of Holland & Hart LLP, please do not send any confidential information by email. If you are not a current client and send an email to an individual at Holland & Hart LLP, you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us, unless we have already agreed to represent you or we later agree to do so. Thus, we may represent a party adverse to you, even if the information you submit to us could be used against you in a matter, and even if you submitted it in a good faith effort to retain us.